Worldwide, considerable research efforts are being directed toward the discovery of novel drugs against human diseases. Enabling technologies have provided much knowledge about disease mechanisms, extremely sensitive assay techniques, and expanding compound libraries, and much of the information resides in computer databases. Despite this massive technological effort the number of truly new drugs available to treat disease is not that great, yet the information may well exist about them. It could be argued that the problem is not the quantity of information, nor necessarily its quality, but the ability to assimilate and act upon it. New developments in software technology, changes in the way in which users expect to interact and use computers, and the opening up and globalization of information networks will impact greatly on the pharmaceutical industry. This paper discusses these developments and provides a somewhat far-reaching vision of a future where computers play a more fundamental role in screening for new drugs.